Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing
HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing
Sponsor: Johns Hopkins University
Terminated
unable to recruit enough patients
Other terminated trials from Johns Hopkins University
A NA clinical study on Burns and Wound Healing, this trial is terminated or withdrawn. The trial is conducted by Johns Hopkins University and has accumulated 8 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Oct 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Oct 2017 [monthly]
Terminated NA
First recorded
Dec 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johns Hopkins University
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institutes of Health (NIH)
For direct contact, visit the study record on ClinicalTrials.gov .